SHPH offering history
Every offering-related filing in Shuttle Pharmaceuticals Holdings, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 296 filings back to Jan 31, 2019.
| Date | Filing | What it means | |
|---|---|---|---|
| May 7, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 1, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 9, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 17, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Feb 11, 2026 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Feb 11, 2026 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 2, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jan 30, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 29, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 11, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Nov 26, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Nov 18, 2025 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Nov 7, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 11, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Aug 11, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 5, 2025 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Jun 25, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Mar 13, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 7, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 5, 2025 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Feb 27, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 27, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 27, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 13, 2025 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Jan 24, 2025 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jan 23, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 22, 2025 | RW → | WITHDRAWN | Registration withdrawn |
| Jan 15, 2025 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Oct 31, 2024 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Oct 29, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 25, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 18, 2024 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Oct 17, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 20, 2024 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Sep 16, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 5, 2024 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
| Mar 22, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 13, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 24, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 1, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
SHPH offering FAQ
When did SHPH last execute an offering?
Per SEC filings, Shuttle Pharmaceuticals Holdings, Inc.'s most recent priced offering document is a 8-K filed 2026-05-07. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did SHPH last announce or register an offering?
The most recent registration is a S-1 filed 2026-02-11. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.